at $6.31. In a 13Dfilingon Spectrum Pharmaceuticals, Armistice Capital disclosed a 5.4% stake in the company. Further, Armistice Capital said it has send a letter to the company requesting it initiate a complete or partial sale suggesting structures based on past transactions for doing so. ...
Here in spectrum our veteran teams with knowledge skill and professionalism gives you the pleasure of quality products and approachable service which makes you come back again. What we do Spectrum Laboratories Plc. engaged in importing & distribution of pharmaceuticals and Medical Device, equipment’s...
A high-level overview of Ocean Park Tactical Risk Spectrum 50 Fund A (SRFQX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
D. Price reports grants or contracts from AstraZeneca, Boehringer Ingelheim, Chiesi, Mylan, Novartis, Regeneron Pharmaceuticals, the Respiratory Effectiveness Group, Sanofi, Theravance, and the UK National Health Service; reports consulting fees from Airway Vista Secretariat, AstraZeneca, Boehringer ...
ofpharmaceuticals,diagnostics,food,beveragesandindustrialfluids.Spectrumpioneeredthedevelopmentof dialysismembranesandaccessories,disposablehollowfiberfiltrationmodulesandsystemsandpreparativelow- pressureliquidchromatographyproducts. Ourmembranesandmembranefiltersareusedformacrofiltration,microfiltration,ultrafiltration,diafiltrationan...
Oddly, Sculley’s attorney, Arnold I. Burns, had every reason to be suspicious of Spectrum. Burns was the lead attorney for ICN Pharmaceuticals in its successful proxy battle with controversial stockbroker Rafi Khan--and Khan had been a major backer of Spectrum stock. Indeed, Caserta at one ...